1 2 aim

EMA recommends first-in-class medicine for treatment of Duchenne muscular dystrophy

Click here for the European Medicines Agency recommendation.

European Neuromuscular Centre (ENMC)

Copyright World Duchenne Organization © 2024

World Duchenne
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.